PHARMGETH
ActiveSummary
PHARMGETH has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €668,073 and a net result of -€5,383. Equity is growing by about 3.4% per year across the filed financial years. Its solvency ranks better than 51% of 3,849 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Articles of association
- Who signsWho may bind the company towards others, for example by signing a contract.
- “VOORZITTER Uit de notulen van de gewone algemene vergadering en de onmiddellijk daaropvolgende raad van bestuur van 02/12/202023 blijkt de…”
Read from the deeds: 1 provision, deed of 21-05-2024